Genomics BioSci & Tech. Co.,Ltd. (TPEX: 4195)
Taiwan
· Delayed Price · Currency is TWD
19.20
+0.10 (0.52%)
Dec 31, 2024, 3:00 PM CST
Genomics BioSci & Tech. Co.,Ltd. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 417.04 | 396.14 | 419 | 389.97 | 443.18 | 427.65 | Upgrade
|
Revenue Growth (YoY) | 2.85% | -5.46% | 7.45% | -12.01% | 3.63% | 13.92% | Upgrade
|
Cost of Revenue | 300.39 | 276.23 | 282.99 | 280.04 | 288.16 | 273.32 | Upgrade
|
Gross Profit | 116.65 | 119.91 | 136.01 | 109.92 | 155.01 | 154.34 | Upgrade
|
Selling, General & Admin | 154.11 | 148.47 | 131.79 | 121.69 | 121.8 | 111.6 | Upgrade
|
Research & Development | 70.62 | 56.43 | 35.88 | 17.47 | 22.56 | 29.77 | Upgrade
|
Operating Expenses | 219.88 | 201.81 | 169.53 | 138.58 | 148.42 | 145.84 | Upgrade
|
Operating Income | -103.23 | -81.9 | -33.52 | -28.66 | 6.6 | 8.49 | Upgrade
|
Interest Expense | -5.79 | -4.79 | -1.98 | -1.67 | -1 | -1.05 | Upgrade
|
Interest & Investment Income | 2.32 | 2.09 | 0.35 | 0.27 | 1.17 | 1.01 | Upgrade
|
Earnings From Equity Investments | -16.48 | -19.56 | -18.88 | -13.46 | 2.89 | -3.05 | Upgrade
|
Currency Exchange Gain (Loss) | 0.64 | 0.86 | 0.72 | -1.31 | -2.44 | - | Upgrade
|
Other Non Operating Income (Expenses) | 0.63 | 0.63 | 0.8 | 1.05 | 0.69 | 7.49 | Upgrade
|
EBT Excluding Unusual Items | -121.9 | -102.67 | -52.5 | -43.78 | 7.91 | 12.89 | Upgrade
|
Gain (Loss) on Sale of Investments | -39.07 | -65.29 | 124.76 | -9.31 | -6.98 | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | 65.18 | -4.04 | - | Upgrade
|
Other Unusual Items | 0 | 0.02 | - | 0.01 | 0 | - | Upgrade
|
Pretax Income | -160.97 | -167.94 | 72.26 | 12.09 | -3.1 | 12.89 | Upgrade
|
Income Tax Expense | - | 0.13 | 0.66 | - | -1.65 | 4.44 | Upgrade
|
Earnings From Continuing Operations | -160.97 | -168.07 | 71.6 | 12.09 | -1.45 | 8.45 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | - | 66.76 | Upgrade
|
Net Income to Company | -160.97 | -168.07 | 71.6 | 12.09 | -1.45 | 75.21 | Upgrade
|
Minority Interest in Earnings | 2.48 | - | - | 6.65 | 2.07 | 9.73 | Upgrade
|
Net Income | -158.49 | -168.07 | 71.6 | 18.74 | 0.62 | 84.94 | Upgrade
|
Net Income to Common | -158.49 | -168.07 | 71.6 | 18.74 | 0.62 | 84.94 | Upgrade
|
Net Income Growth | - | - | 282.09% | 2927.14% | -99.27% | - | Upgrade
|
Shares Outstanding (Basic) | 72 | 71 | 63 | 60 | 60 | 60 | Upgrade
|
Shares Outstanding (Diluted) | 72 | 71 | 64 | 60 | 60 | 61 | Upgrade
|
Shares Change (YoY) | 8.03% | 11.87% | 5.12% | 0.23% | -0.47% | 0.63% | Upgrade
|
EPS (Basic) | -2.19 | -2.36 | 1.13 | 0.31 | 0.01 | 1.41 | Upgrade
|
EPS (Diluted) | -2.19 | -2.36 | 1.13 | 0.31 | 0.01 | 1.40 | Upgrade
|
EPS Growth | - | - | 267.48% | 3103.13% | -99.31% | - | Upgrade
|
Free Cash Flow | -288.02 | -246.28 | -115.21 | -121.35 | -61.53 | 57.36 | Upgrade
|
Free Cash Flow Per Share | -3.98 | -3.46 | -1.81 | -2.01 | -1.02 | 0.95 | Upgrade
|
Dividend Per Share | - | - | 0.098 | - | - | 1.153 | Upgrade
|
Gross Margin | 27.97% | 30.27% | 32.46% | 28.19% | 34.98% | 36.09% | Upgrade
|
Operating Margin | -24.75% | -20.67% | -8.00% | -7.35% | 1.49% | 1.99% | Upgrade
|
Profit Margin | -38.00% | -42.43% | 17.09% | 4.81% | 0.14% | 19.86% | Upgrade
|
Free Cash Flow Margin | -69.06% | -62.17% | -27.50% | -31.12% | -13.88% | 13.41% | Upgrade
|
EBITDA | -56.83 | -49.01 | -5.41 | 0.81 | 37.72 | 42.31 | Upgrade
|
EBITDA Margin | -13.63% | -12.37% | -1.29% | 0.21% | 8.51% | 9.89% | Upgrade
|
D&A For EBITDA | 46.4 | 32.89 | 28.1 | 29.47 | 31.12 | 33.82 | Upgrade
|
EBIT | -103.23 | -81.9 | -33.52 | -28.66 | 6.6 | 8.49 | Upgrade
|
EBIT Margin | -24.75% | -20.67% | -8.00% | -7.35% | 1.49% | 1.99% | Upgrade
|
Effective Tax Rate | - | - | 0.92% | - | - | 34.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.